$443.34−17.91 (−3.88%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$443.32−0.02 (0.00%)
After hours: Nov 17, 2026, 6:25 PM ET
Humana (HUM) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~11.8%/yr (FY21→FY25), net margin 0.9%; free cash flow runs at 31% of net income. Check the accrual gap. Worth your attention in FY25: Returns vs FCF (155%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲10.1%
129,664.0
FY21→FY25CAGR +11.8%/yr
Net income ($M)▼1.6%
1,188.0
FY21→FY25CAGR −20.2%/yr
Free cash flow ($M)▼84.3%
375.0
FY21→FY25CAGR −20.1%/yr
Diluted EPS▼1.4%
9.84
buyback-liftedCAGR −18.8%/yr
What the receipts whisper · what a headline number hides
Share count
−4.8%
126.6mn → 120.6mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$546.0M
steady at 0.4% of revenue (−5.0% YoY).
Returns vs FCF
155%
$581.0M returned vs $375.0M of FCF in FY25. The gap comes off the balance sheet (see net cash).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)
1¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 16.7% → 14.5%. Net margin 0.9% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 154,185.0 | 129,664.0 | 117,761.0 | 106,374.0 | 92,870.0 | 83,064.0 | ▲10.1% | +11.8% |
Cost of revenue | 134,122.0 | 110,812.0 | 100,664.0 | 88,394.0 | 75,690.0 | 69,199.0 | ▲10.1% | +12.5% |
Gross profit | 20,063.0 | 18,852.0 | 17,097.0 | 17,980.0 | 17,180.0 | 13,865.0 | ▲10.3% | +8.0% |
Selling, general & admin | 17,038.0 | 15,450.0 | 13,696.0 | 13,188.0 | 12,671.0 | 10,121.0 | ▲12.8% | +11.2% |
Total operating expenses | 17,682.0 | 16,148.0 | 14,535.0 | 13,967.0 | 13,380.0 | 10,717.0 | ▲11.1% | +10.8% |
Operating incomefeeds ROC rank | 2,381.0 | 2,704.0 | 2,562.0 | 4,013.0 | 3,800.0 | 3,148.0 | ▲5.5% | −3.7% |
Other income, net | −629.0 | −1,149.0 | −841.0 | −630.0 | −232.0 | 206.0 | — | — |
Pretax income | 1,752.0 | 1,555.0 | 1,721.0 | 3,383.0 | 3,568.0 | 3,354.0 | ▼9.6% | −17.5% |
Income tax | 424.0 | 250.0 | 413.0 | 836.0 | 762.0 | 485.0 | ▼39.5% | −15.3% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 1,246.0 | 1,188.0 | 1,207.0 | 2,489.0 | 2,806.0 | 2,934.0 | ▼1.6% | −20.2% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 10.30 | 9.84 | 9.98 | 20.00 | 22.08 | 22.67 | ▼1.4% | −18.8% |
Diluted shares (mn) | 120.10 | 120.60 | 120.64 | 120.65 | 124.97 | 126.63 | ▼0.0% | −1.2% |
| Margins | ||||||||
Gross margin3rd pct in Healthcare | 13.0% | 14.5% | 14.5% | 16.9% | 18.5% | 16.7% | ▲0.0pp | −2.2pp |
Operating margin | 1.5% | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | ▼0.1pp | −1.7pp |
Net margin42nd pct in Healthcare | 0.8% | 0.9% | 1.0% | 2.3% | 3.0% | 3.5% | ▼0.1pp | −2.6pp |
† TTM = trailing four quarters through 2026-09-30.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Humana's revenue last fiscal year?
Humana reported revenue of $129,664.0M in fiscal 2025, up 10.1% from fiscal 2024.
What was Humana's net income?
Humana reported net income of $1,188.0M in fiscal 2025, a net margin of 0.9%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

